在2型炎症相关呼吸道疾病中IL-33的产生,功能和临床应用
Shiyao Gu1, Ruixuan Wang2, Wantian Zhang1
1Department of Anesthesiology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
介质素-33 (IL-33) 作为一个警报信号,在喘等肺部疾病中促进2型炎症. 准IL-33为预防和治疗这些疾病提供了新的策略.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 细胞生物学 细胞生物学
背景情况:
- 介素-33 (IL-33) 是一种由表皮衍生的警报信号分子.
- 由Th2细胞和ILC2s介导的2型炎症与喘和COPD等肺部疾病有关.
- 人们越来越认识到IL-33在促进肺部2型炎症中的作用.
研究的目的:
- 提供IL-33在2型炎症性肺病中的机制和点的概述.
- 总结这些条件的当前治疗策略.
- 探索IL-33作为预防肺病的潜在治疗点.
主要方法:
- 文献综述和对IL-33和2型炎症现有研究的分析.
- 检查IL-33在肺部疾病发病的作用.
- 综合有关治疗干预和目标的信息.
主要成果:
- IL-33作为肺部2型炎症的关键发起者和放大器.
- 已经确定了IL-33在肺部疾病发展中的特定机制和细胞点.
- 目前正在研究针对IL-33通路的各种治疗方法.
结论:
- IL-33是2型炎症性肺部疾病中的关键调解剂.
- 了解IL-33的作用为疾病病原发生提供了新的见解.
- 向IL-33为肺部疾病的预防和治疗提供了有希望的治疗策略.
更多相关视频
08:38A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model
Published on: March 3, 2023
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023
相关概念视频
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
